MoneyWeek magazine
-

How a dovish Federal Reserve could affect you
Trump’s pick for the US Federal Reserve is not so much of a yes-man as his rival, but interest rates will still come down quickly, says Cris Sholto Heaton
By Cris Sholto Heaton Published
-

New Federal Reserve chair Kevin Warsh has his work cut out
Opinion Kevin Warsh must make it clear that he, not Trump, is in charge at the Fed. If he doesn't, the US dollar and Treasury bills sell-off will start all over again
By Matthew Lynn Published
Opinion -

How Canada's Mark Carney is taking on Donald Trump
Canada has been in Donald Trump’s crosshairs ever since he took power and, under PM Mark Carney, is seeking strategies to cope and thrive. How’s he doing?
By Simon Wilson Published
-

Share tips 2026: this week’s top stock picks
Share tips Share tips 2026: MoneyWeek’s roundup of the top stock picks this week – here’s what the experts think you should buy
By MoneyWeek Last updated
Share tips -

Adventures in Saudi Arabia
Travel The kingdom of Saudi Arabia in the Middle East is rich in undiscovered natural beauty. Get there before everybody else does, says Merryn Somerset Webb
By Merryn Somerset Webb Published
Travel -

8 of the best houses for sale for around £500,000
The best houses for sale for around £500,000 – from a navigable 1920s Dutch barge on a marina in Isleworth, London, to a basement apartment in Clifton, Bristol
By Natasha Langan Last updated
-

Three companies with deep economic moats to buy now
Opinion An economic moat can underpin a company's future returns. Here, Imran Sattar, portfolio manager at Edinburgh Investment Trust, selects three stocks to buy now
By Imran Sattar Published
Opinion -

Long live Dollyism! Why Dolly Parton is an example to us all
Dolly Parton has a good brain for business and a talent for avoiding politics and navigating the culture wars. We could do worse than follow her example
By Jane Lewis Published
-

Should you sell your Affirm stock?
Affirm, a buy-now-pay-later lender, is vulnerable to a downturn. Investors are losing their enthusiasm, says Matthew Partridge
By Dr Matthew Partridge Published
